NEW YORK, Oct 31 – Transgenomic of Omaha, Neb., said Tuesday revenues from its life science business soared 68 percent to $6.25 million in the third quarter from $5.60 million a year ago, due to increased demand from research and commercial organizations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.